Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2014-04-16

FDA Approved: CELEXA — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Celexa (citalopram) by Allergan, Inc., for a label update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CELEXA (citalopram)

Snippet

SUPPL AP for CELEXA (CITALOPRAM)